GFACX
Price
$74.18
Change
-$1.66 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
SMITX
Price
$33.33
Change
-$1.10 (-3.19%)
Updated
Nov 13 closing price
Net Assets
3.76B
Interact to see
Advertisement

GFACX vs SMITX

Header iconGFACX vs SMITX Comparison
Open Charts GFACX vs SMITXBanner chart's image
American Funds Growth Fund of Amer C
Price$74.18
Change-$1.66 (-2.19%)
VolumeN/A
Net Assets340.4B
Invesco Summit R5
Price$33.33
Change-$1.10 (-3.19%)
VolumeN/A
Net Assets3.76B
GFACX vs SMITX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. SMITX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and SMITX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 340B vs. SMITX (3.76B). GFACX (0.00) and SMITX (0.00) have matching dividends . GFACX was incepted earlier than SMITX: GFACX (25 years) vs SMITX (17 years). GFACX (1.36) is less costly to investors than SMITX (0.69). SMITX is a more actively managed with annual turnover of: 57.00 vs. GFACX (25.00). GFACX has a lower initial minimum investment than SMITX: GFACX (250) vs SMITX (1000000). SMITX annual gain was more profitable for investors over the last year : 12.15 vs. GFACX (4.61). GFACX return over 5 years is better than : 27.87 vs. SMITX (17.55).
GFACXSMITXGFACX / SMITX
Total Expense Ratio1.360.69197%
Annual Report Gross Expense Ratio1.360.69197%
Fund Existence25 years17 years-
Gain YTD16.34314.347114%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets340B3.76B9,040%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.6112.1538%
Returns for 3 years56.1777.2073%
Returns for 5 years27.8717.55159%
Returns for 10 years75.7899.6076%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAX18.70N/A
N/A
Baxter International
OFG40.72-0.03
-0.07%
OFG Bancorp
CVGW21.90-0.23
-1.04%
Calavo Growers
FBIOP6.53-0.27
-3.97%
Fortress Biotech
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics